|  |  |  |  |  |
| Company | IBL-America | IBL-America | IBL-America | IBL-America | IBL-America |
| Item | Human Titin N-Fragment (Serum) ELISA | Anti-Trastuzumab (Herceptin®) ELISA | sAPP Alpha (Highly Sensitive) ELISA Assay | T3 (Free) ELISA Assay | Thyroid Stimulating Hormone ELISA Assay |
| Citations | | | | | |
| Catalog Number | 27902 | TM09015 | 27734 | IB19105N | IB19109 |
| Price | Supplier Page | Supplier Page | Supplier Page | Supplier Page | Supplier Page |
| Description | Solid phase sandwich ELISA designed for the determination of Titin N fragment in human serum. For research use only, not for use in diagnostic procedures. | Enzyme immunoassay (ELISA) test kit for the determination of free antibodies directed against the drug Trastuzumab (Herceptin®, Herclon®) in serum and plasma. For research use only, not for use in diagnostic procedures. | Solid phase sandwich ELISA for the determination human sAPPa in serum, EDTA plasma, cerebrospinal fluids and cell culture supernatant. For research use only, not for use in diagnostic procedures. | Solid phase competitive enzyme immunoassay (ELISA) for the determination of free Triiodothyronine (fT3) in human serum. FDA exempt, can be used for in-vitro diagnostics. | Solid phase sandwich enzyme immunoassay (ELISA) for the determination of TSH in human serum. For research use only, not for diagnostic procedures. |
| Detection Target | Human Titin N-Fragment | Ranibizumab (Lucentis®) (mAb-based) | C3a Des Arg | Amyloid Beta (1-38) (FL) | Thyroid Stimulating Hormone |
| Sample Type | Serum, Blood Plasma | Aqueous humour | Blood Plasma | CSF, Cell Culture Supernatant | Serum |
| Method | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) |
| Detection Range | 0 / 46.88 - 3000 pmol/L | 0 / 30 - 1000 ng/mL | 0.78 to 50 ng/mL | 1.2 to 18 pg/mL | 0.5 to 40 µIU/mL |
| Sensitivity | 99.25% (95% confidence interval: 95.88% - 99.98%) | 0.33 ng/mL | Inquire | 1.28 pg/mL | 0.05 µIU/mL |
| Assay Time | Incubation Overnight (2-8C) + 60 min. (2-8C) + 30 min. (RT) = Overnight + 1.5 hours total incubation time. | 2 hours, 15 min. total incubation time. | Overnight + 1 hr (incubation) | 1 hr 15 mins (incubation) | 1 hr 15 mins (incubation) |
| Get Quote | Supplier Page | Supplier Page | Supplier Page | Supplier Page | Supplier Page |